v1
Rituximab, Bendamustine and Cytarabine Followed By Venetoclax (V-RBAC) in High-Risk Older Patients with Mantle Cell Lymphoma: A Phase 2 Study By the Fondazione Italiana Linfomi (FIL)
NobleIDNI1P87W82R08S68
Type:Journal Article
0 views
Embeddable Badge
[](https://nobleid.org/work/w1/20260521/8DBDFDA9)
ARK Inflections
Metadata Formats
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →